Let’s Talk About Non-Responders in Psychedelic Therapy | Chemical Collective
For a decade, many headlines, documentaries, and investor pitch decks have sold a singular story: that compounds like psilocybin and MDMA are capable of resetting the depressed brain and resolving trauma overnight. On August 9, 2024, that narrative collided with regulatory reality.